Smith & Nephew agreed to pay more than $22.2 million in fines and profit disgorgement, maintain an enhanced compliance program and appoint an independent monitor for at least 18 months to review the program.
The company was one of multiple medical device companies asked to investigate improper payments to government-employed physicians and voluntarily report issues in 2007. The company found and reported payments by a Greek distributor, which was terminated in 2008.
The company provided for the payment in its fourth quarter 2011 earnings.
Related Articles on Orthopedic Device Companies:
TeDan Surgical Innovations Launches Minimally Invasive Anterior Hip Retractor System
ConforMIS Received 22 Patents Over Last Year
Exactech Reports 21% Decline in 4Q Spine & Biologics Sales
a
Smith & Nephew Pays $22.2M Settlement in SEC Investigation
Written by Laura Miller | February 07, 2012
Smith & Nephew has reached a settlement with the U.S. Securities and Exchange Commission and the U.S. Department of Justice in connection with their Foreign Corrupt Practices Act investigation, according to a company news release.
© Copyright ASC COMMUNICATIONS 2011. Interested in LINKING to or REPRINTING this content? View our policies here.
